Advertisement Biotronik launches new coronary sinus leads - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Biotronik launches new coronary sinus leads

Biotronik has introduced two new bipolar coronary sinus leads for use in the left ventricle for cardiac resynchronization therapy.

Biotronik’s Corox OTW BP and Corox OTW S-BP leads offer a design that allows them to fixate in even unusual coronary vessel anatomies, which can preclude the use of other leads. They are designed for use in patients with heart failure.

The Corox OTW BP and S-BP leads offer new technology that can help overcome the difficulties of navigating to the left side of heart and assuring that the left-ventricular leads achieve stable fixation. Together, these new bipolar left-heart leads can work in the broad range of coronary vessels implanting physicians confront daily in clinical practice. These new leads developed by Biotronik are said to provide smoother implantations with fewer complications and ensure stronger performance over the long term.